Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 22%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is poised for long-term success due to its diversified portfolio of healthcare real estate properties, strong balance sheet, and attractive investment opportunities. The company's recent portfolio updates, including the transition of 26 Avamere-leased properties to Cascadia Healthcare and a reduction in behavioral health exposure, demonstrate management's commitment to optimizing its assets and improving cash flow. SBRA's focus on acquiring newer senior housing assets at attractive lease yields further supports its potential for internal and external growth.

Bears say

Sabra Health Care REIT is facing challenges in their business model, as seen in their overall decrease in revenue. The concentration of their operations in the United States leaves them vulnerable to changes in healthcare policies and regulations. Despite small agreements and tenant resolutions increasing annual NOI, the overall impact is not enough to counterbalance the negative outlook on the company's fundamentals. Furthermore, the increase in G&A expenses and revised FFO guidance point to potential financial struggles in the future.

SBRA has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 22% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 9 analysts, SBRA has a Hold consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.